IFIH1 and dermatomyositis: Articles reporting development of MDA5+ DM after Covid-19 vaccination, cases of DM without anti-MDA5 antibodies, MDA5+ DM not associated with COVID-19 infection, and MDA5+ DM pre-existing before COVID-19 infection were excluded.